The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Takeda. The supporters have no influence over the production of the content.
Welcome to The Aggressive & Diffuse Large B-Cell Lymphoma Channel
VJHemOnc shares important updates on aggressive & diffuse large B-cell lymphoma, a common lymphoid malignancy in adults accounting for 30% of malignant lymphomas. The Aggressive & Diffuse Large B-Cell Lymphoma Channel provides unique perspectives from distinguished experts around the world in the form of video interviews, podcasts, and roundtable discussions.
Explore the latest research into novel therapies including CAR-T cells, immunomodulators, and antibody-drug conjugates on The Aggressive & Diffuse Large B-Cell Lymphoma Channel.
Burkitt
Lymphoma
View all
The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Takeda.
The supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
